Bristol-Myers Squibb Company (BMY)

Home
BMY
Financials

45.85 (USD) • At close August 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987
Revenue Numbers are in millions	48,300	45,006	46,159	46,385	42,518	26,145	22,561	20,776	19,427	16,560	15,879	16,385	17,621	21,244	19,484	18,808	20,597	19,348	17,914	19,207	19,380	20,894	18,119	19,423	18,216	20,222	18,284	16,701	15,065	13,767	11,984	11,413	11,156	11,159	10,300	9,189	8,558	7,558
Cost of Revenue Numbers are in millions	20,868	19,649	19,669	19,624	20,818	8,895	6,486	5,818	4,932	3,754	3,879	4,585	4,433	5,523	5,154	5,031	6,156	6,141	5,572	5,826	5,812	7,592	6,388	5,575	4,013	4,861	4,231	3,873	3,446	3,189	2,794	2,721	2,562	2,684	2,630	2,460	2,299	2,141
Gross Profit Numbers are in millions	27,432	25,357	26,490	26,761	21,700	17,250	16,075	14,958	14,495	12,806	12,000	11,800	13,188	15,721	14,330	13,777	14,441	13,207	11,684	13,381	13,568	13,302	11,731	13,848	14,203	15,361	14,053	12,828	11,619	10,578	9,190	8,692	8,594	8,475	7,670	6,729	6,259	5,417
Gross Profit Ratio Numbers are in millions	0.568	0.762	0.78	0.786	0.723	0.691	0.71	0.708	0.745	0.764	0.752	0.718	0.738	0.736	0.729	0.727	0.701	0.679	0.668	0.691	0.691	0.637	0.647	0.713	0.78	0.76	0.769	0.768	0.771	0.768	0.767	0.762	0.77	0.759	0.745	0.732	0.731	0.717
Reseach & Development Expenses Numbers are in millions	9,782	9,207	9,411	9,533	9,557	5,949	5,131	4,969	4,405	4,037	4,043	3,731	3,904	3,839	3,566	3,647	3,224	3,120	2,906	2,674	2,442	2,279	2,218	2,259	1,939	1,843	1,577	1,385	1,276	1,199	1,108	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,660	3,923	3,903	3,860	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,416	1,295	1,433	1,672	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	7,992	7,678	7,808	7,688	7,651	4,862	4,550	4,750	4,911	4,831	4,822	4,939	5,017	5,131	4,628	5,082	6,342	6,320	6,136	6,582	6,427	6,076	5,218	5,336	5,532	6,987	6,730	6,414	5,871	5,316	4,533	5,981	6,339	5,463	5,037	5,450	4,304	3,789
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	746	678	625	591	519	448	328	308	295	246	244	196	185	161
Operating Expenses Numbers are in millions	17,774	16,885	17,219	17,221	17,208	10,811	9,681	9,719	9,316	8,868	8,865	8,670	8,921	8,970	8,194	8,729	9,566	9,440	9,042	9,256	8,869	8,355	7,436	7,595	8,217	9,508	8,932	8,390	7,666	6,963	5,969	6,289	6,634	5,709	5,281	5,646	4,489	3,950
Operating Income Numbers are in millions	9,658	8,472	9,271	9,540	4,492	6,439	6,394	5,239	5,179	3,938	3,135	3,130	4,267	6,751	6,136	5,048	4,875	3,767	2,642	4,125	4,699	4,933	4,101	5,158	5,986	5,239	4,456	4,438	3,953	3,615	3,221	2,403	1,960	2,766	2,389	1,083	1,770	1,467
Operating Income Ratio Numbers are in millions	0.2	0.182	0.197	0.184	0.051	0.226	0.227	0.166	0.23	0.104	0.108	0.179	0.223	0.312	0.305	0.289	0.244	0.182	0.133	0.195	0.23	0.236	0.226	0.266	0.329	0.259	0.244	0.266	0.262	0.263	0.269	0.211	0.176	0.248	0.232	0.118	0.207	0.194
Total Other Income Expenses Net Numbers are in millions	-18,037	-32	-1,558	-1,442	-11,363	-1,464	-426	-108	736	-1,861	-754	-239	-1,927	230	-65	554	596	-233	-242	391	-281	-253	-1,340	-2,940	-508	-81	-818	44	60	-1,213	-666	168	27	121	135	194	119	161
Income Before Tax Numbers are in millions	-8,379	8,440	7,713	8,098	-6,871	4,975	5,968	5,131	5,915	2,077	2,381	2,891	2,340	6,981	6,071	5,602	4,776	3,534	2,400	4,304	4,418	4,680	2,761	2,218	5,478	5,158	3,638	4,482	4,013	2,402	2,555	2,571	1,987	2,887	2,524	1,277	1,889	1,628
Income Before Tax Ratio Numbers are in millions	-0.173	0.188	0.167	0.175	-0.162	0.19	0.265	0.247	0.304	0.125	0.15	0.176	0.133	0.329	0.312	0.298	0.232	0.183	0.134	0.224	0.228	0.224	0.152	0.114	0.301	0.255	0.199	0.268	0.266	0.174	0.213	0.225	0.178	0.259	0.245	0.139	0.221	0.215
Income Tax Expense Numbers are in millions	554	400	1,368	1,084	2,124	1,515	1,021	4,156	1,408	446	352	311	-161	1,721	1,558	1,182	1,090	803	538	870	1,519	1,210	391	73	1,382	1,369	888	1,277	1,163	590	713	612	449	831	776	530	635	560
Net Income Numbers are in millions	-8,948	8,025	6,327	6,994	-8,995	3,439	4,920	1,007	4,457	1,565	2,004	2,563	1,960	3,709	3,102	10,612	5,247	2,165	1,585	3,000	2,388	3,106	2,137	4,834	4,711	4,167	3,141	3,205	2,850	1,812	1,842	1,959	1,962	2,056	1,748	747	1,254	1,068
Net Income Ratio Numbers are in millions	-0.185	0.178	0.137	0.151	-0.212	0.132	0.218	0.048	0.229	0.095	0.126	0.156	0.111	0.175	0.159	0.564	0.255	0.112	0.088	0.156	0.123	0.149	0.118	0.249	0.259	0.206	0.172	0.192	0.189	0.132	0.154	0.172	0.176	0.184	0.17	0.081	0.147	0.141
EPS Numbers are in millions	-4.41	3.88	2.97	3.15	-3.98	2.02	3.03	0.61	2.67	0.97	1.21	1.56	1.17	2.18	1.81	5.38	2.65	1.1	0.81	1.54	1.23	1.6	1.03	2.7	2.4	2.1	1.58	1.61	1.42	0.9	0.9	0.95	0.96	0.99	0.84	0.36	0.6	0.5
EPS Diluted Numbers are in millions	-4.41	3.86	2.95	3.12	-3.98	2.01	3.03	0.61	2.65	0.97	1.2	1.54	1.16	2.16	1.8	5.37	2.62	1.09	0.81	1.51	1.21	1.59	1.02	2.67	2.36	2.06	1.55	1.57	1.4	0.89	0.9	0.95	0.96	0.99	0.84	0.36	0.6	0.5
EBITDA Numbers are in millions	3,168	19,366	19,221	20,118	4,929	7,377	6,788	6,116	6,464	2,637	3,051	3,853	3,203	7,754	6,823	6,493	5,902	4,420	3,313	4,666	5,373	5,722	4,836	5,886	6,732	5,917	5,081	5,029	4,472	4,063	3,549	2,711	2,255	3,012	2,633	1,279	1,955	1,628
EBITDA Ratio Numbers are in millions	0.066	0.43	0.416	0.434	0.116	0.282	0.301	0.294	0.333	0.159	0.192	0.235	0.182	0.365	0.35	0.345	0.287	0.228	0.185	0.243	0.277	0.274	0.267	0.303	0.37	0.293	0.278	0.301	0.297	0.295	0.296	0.238	0.202	0.27	0.256	0.139	0.228	0.215

Bristol-Myers Squibb Company

NYSE:BMY Add to watchlist

NYSE:BMY